Definition of five new simian immunodeficiency virus cytotoxic T-lymphocyte epitopes and their restricting major histocompatibility complex class I molecules: Evidence for an influence on disease progression

被引:68
作者
Evans, DT
Jing, PC
Allen, TM
O'Connor, DH
Horton, H
Venham, JE
Piekarczyk, M
Dzuris, J
Dykhuzen, M
Mitchen, J
Rudersdorf, RA
Pauza, CD
Sette, A
Bontrop, RE
DeMars, R
Watkins, DI
机构
[1] Univ Wisconsin, Wisconsin Reg Primate Res Ctr, Madison, WI 53715 USA
[2] Univ Wisconsin, Genet Lab, Madison, WI 53715 USA
[3] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53715 USA
[4] Epimmune Inc, San Diego, CA 92121 USA
[5] TNO, Biomed Primate Res Ctr, NL-2280 HV Rijswijk, Netherlands
关键词
D O I
10.1128/JVI.74.16.7400-7410.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Simian immunodeficiency virus (SIV) infection of the rhesus macaque is currently the best animal model for AIDS vaccine development. One limitation of this model, however, has been the small number of cytotoxic T-lymphocyte (CTL) epitopes and restricting major histocompatibility complex (MHC) class I molecules available for investigating virus-specific CTL responses. To identify new MBC class I-restricted CTL epitopes, we infected five members of a family of MHC-defined rhesus macaques intravenously with STY, Five new CTL epitopes bound by four different MHC class I molecules were defined. These included two Env epitopes bound by Mamu-A*11 and -B*03 and three Nef epitopes bound by Mamu-B*03, -B*04, and -B*17. All four restricting MHC class I molecules were encoded on only two haplotypes (b or c). Interestingly, resistance to disease progression within this family appeared to be associated with the inheritance of one or both of these MNC class I haplotypes, Two individuals that inherited haplotypes b and c separately survived for 299 and 511 days, respectively, while another individual that inherited both haplotypes survived for 889 days. In contrast, two MHC class I-identical individuals that did not inherit either haplotype rapidly progressed to disease (survived <80 days). Since all five offspring were identical at their Mamu-DRB loci, MNC class II differences are unlikely to account for their patterns of disease progression. These results double the number of SIV CTL epitopes defined in rhesus macaques and provide evidence that allelic differences at the MBC class I loci may influence rates of disease progression among AIDS virus-infected individuals.
引用
收藏
页码:7400 / 7410
页数:11
相关论文
共 48 条
[1]   Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen [J].
Allen, TM ;
Vogel, TU ;
Fuller, DH ;
Mothé, BR ;
Steffen, S ;
Boyson, JE ;
Shipley, T ;
Fuller, J ;
Hanke, T ;
Sette, A ;
Altman, JD ;
Moss, B ;
McMichael, AJ ;
Watkins, DI .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4968-4978
[2]  
Allen TM, 1998, J IMMUNOL, V160, P6062
[3]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[4]   VIRUS-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTE ACTIVITY ASSOCIATED WITH CONTROL OF VIREMIA IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
BORROW, P ;
LEWICKI, H ;
HAHN, BH ;
SHAW, GM ;
OLDSTONE, MBA .
JOURNAL OF VIROLOGY, 1994, 68 (09) :6103-6110
[5]  
Boyson JE, 1996, J IMMUNOL, V156, P4656
[6]  
Boyson JE, 1997, J IMMUNOL, V159, P3311
[7]   HLA and HIV-1:: Heterozygote advantage and B*35-Cw*04 disadvantage [J].
Carrington, M ;
Nelson, GW ;
Martin, MP ;
Kissner, T ;
Vlahov, D ;
Goedert, JJ ;
Kaslow, R ;
Buchbinder, S ;
Hoots, K ;
O'Brien, SJ .
SCIENCE, 1999, 283 (5408) :1748-1752
[8]   PRESENTATION OF AN IMMUNODOMINANT T-CELL EPITOPE OF HEPATITIS-B SURFACE-ANTIGEN BY THE HLA-DPW4 MOLECULE [J].
CELIS, E ;
KARR, RW .
JOURNAL OF VIROLOGY, 1989, 63 (02) :747-752
[9]  
Dailey P. J., 1995, Journal of Medical Primatology, V24, P209
[10]   Update:: Immunology -: The numbers game for virus-specific CD8+ T cells [J].
Doherty, PC .
SCIENCE, 1998, 280 (5361) :227-227